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Experiments have been described indicating that  a  vaccine containing ap- 
proximately 50,000  mouse  intracerebral lethal doses  of rabies virus properly 
irradiated will immunize mice, and that  25,000,000  doses will immunize dogs 
against  a  subsequent  test  inoculation  of  virulent  virus.  Additional experi- 
ments showed that a  volume of 0.1 cc. of an irradiated vaccine prepared from 
the  supernatant  of  centrifuged  virus-containing dog  brain  contained  the  re- 
quired 50,000 doses and immunized mice adequately (1).  It remained to deter- 
mine whether the required number of mouse doses to immunize dogs could b 
concentrated into a  small volume and whether a  single injection of such a va~ 
cine would in fact protect them adequately. 
Technique 
To prepare vaccine, 2-months-old beagle dogs are injected intracerebrally with 0.5 
cc. of a  1 : 10 dilution of dog brain virus, Pasteur strain.  When the animals become 
prostrate, they are sacrificed, their brains are removed, triturated in an electric mixer, 
and diluted in distilled water containing 2  per cent citric acid-sodium diphosphate 
buffer (Mcllvaine), pH 7.2--to make a 1 or 5 per cent emulsion.  This emulsion is then 
centrifuged at 500 ~.P.M. for 5 minutes and the supernatant removed.  The superna- 
tant must be relatively free from large particles to insure that ultraviolet light will 
render it non-virulent and yet not destroy its immunizing potency.  It must also titre 
at least 330,000 mouse doses per ml., that is, prove fatal to W-Swiss mice when injected 
intracerebrally in 0.03 cc. volumes and in a dilution of 10  -4, to insure that small vol- 
umes of the final vaccine will immunize animals effectively.  The material is rendered 
non-virulent by exposure to ultraviolet light for 35 minutes (2).  Tests for sterility are 
made, merthiolate in a dilution of 1 : 10,000 is added as preservative, and the material, 
ready for use, is stored in the ice box at 40°F. 
The technique which we have employed for testing rabies vaccines in dogs has been 
described in a previous paper (3).  Beagle dogs, aged 4 to 6 months, are used for the 
most part in all tests.  In some, however, it has been necessary to include animals of 
mixed small breeds of the same age.  They are wormed as soon as received on the 
premises and then given 10 to 15 cc. of distemper immune serum, followed by one or 
two injections of non-virulent distemper vaccine. 
About 7 days after arrival, groups of six to twelve animals receive rabies vaccine and 
a remaining group is set aside as controls. 
Three weeks later all are given a  test injection of rabies virus, 0.25 cc. properly di- 
luted, deep into the neck muscles of each side,  They are then watched for signs of 
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rabies for 2 to 5 months.  The animals which become prostrate are sacrificed,  their 
brains removed, tested for the presence of Negri bodies in stained impressions, and for 
the presence of rabies virus by inoculation of diluted brain suspension  intracerebraUy 
into mice.  The survivors are also sacrificed when the experiment is terminated and 
their brains tested for the presence of rabies virus. 
Results of Tests on Unvaccinated Dogs 
In attempting to evaluate experiments on the immunizing effects of vaccines 
on experimental animals, a  factor of prime importance is the regularity of re- 
sponse of unvaccinated controls to the test virus.  When small animals, such 
as mice, are employed, it is possible to exert such a degree of control that not 
only  unvaccinated  animals  respond  in  a  uniform  and  predictable  manner 
within narrow limits, but the actual amount of virus administered can be deter- 
mined in terms of minimum lethal doses.  When large and expensive animals 
are employed, such as the monkey or dog, the problem becomes more difficult, 
although the aims remain the same, namely, to set up conditions which will in- 
sure uniform and predictable mortalities among unvaccinated animals. 
These aims have been realized in part only.  English investigators in India 
(4, 5), studying the potency of rabies vaccines in monkeys, found that mortali- 
ties in unvaccinated groups following the test injection of virus varied from 20 
to 100 per cent in different experiments.  More recently, Johnson and Leach 
(6) carried out repeated tests of vaccines in thirteen groups of seven to ten dogs 
and found that the mortalities among unvaccinated dogs varied unpredictably 
from 20 to 91 per cent.  They attribute such "fallacious results" to chance and 
carried out repeated tests until the total number of animals "satisfied statistical 
requirements"  (6).  They also performed a  single  experiment with  fifty-five 
control dogs which they regarded as sufficient to eliminate the effects of chance 
variables encountered in their type of test.  We have been more fortunate in 
controlling chance variables in our experiments with smaller groups of animals 
and have obtained results in unvaccinated dogs which show little variation from 
experiment to experiment.  In six tests shown in Table I, the mortalities among 
the unvaccinated dogs averaged 83 per cent and were never less than  71  nor 
more than 88 per cent except in one instance in which the mortality was 100 
per cent.  These results have been similar in all eighteen tests in that the con- 
trols showed mortalities as great as 100 per cent but never less than 71 per cent 
except on two occasions when mortalities were 60 and 50 per cent respectively. 
The duration of life of these animals varied widely: 39.6 per cent in  12 to 19 
days; 27 per cent in 20 to 29 days; 16.6 per cent in 30 to 60 days, and 16.6 per 
cent remained well more than 90 days.  This means that 66.6 per cent of the 
animals died within the first month.  Under natural conditions of street infec- 
tion, probably not more than 20 per cent die during a similar period. 
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dictable results in mortalities following injection of groups of five to eleven con- 
trol dogs with rabies virus, we have not been successful in eliminating com- 
pletely complicating factors of intercurrent infection--in our case, distemper. 
The British workers referred to above lost as  many as  20 per cent of their 
animals from intercurrent infections--chiefly among the vaccinated groups-- 
and hence compared vaccinated and unvaccinated groups at 2 rather than 3 
months following infection.  Leach and Johnson, in their thirteen tests with 
small batches of dogs, lost not only 49 per cent of the original 149 controls from 
the experimental inoculation with rabies virus, but also 19 per cent from other 
TABLE I 
Mortality of Unvaccinated Control Dogs, Tests 10-18, Following Intramuscular Inoculation 
oJ Virus 
Test  Virus 
10  Fixed 
No. 15811 
12  Fixed 
No. 15811 
13  Fixed 
No. 15811 
15  Fixed 
No. 15811 
16  Street 
(1  passage) 
18  Street 
[(1  passage) 
Dilu-  No. of dogs dying from rabies on given days following inoculation 
tion  12 13 15 16 17 18 19  -  -- ....  ~__  T0tai  Dead  20 21 23 24 25 2724  30  34  37  41  Survivors 
1:,~  1,[  i  l~----  1  4/s 
,00  i,j],2j,  i  ,j  ,j  it2  j,:,j,,, 
I  19/48--39.6  13/48--27  ][  8/48--16.6  1[8/48--16.6] 40/48  [ 83.3 
I  12Pt:r19dtays  [  percent  JI  percent  II  percent  ~  / 
20 to 29 days//  3o to 60 days  l1 Survived [  [ 
causes; they also lost 18.6 per cent of the original 140 vaccinated dogs from the 
experimental inoculation and an additional 25 per cent from other causes.  The 
effect of uncontrolled variables was therefore equal to 40 per cent of, or even 
exceeded, the total effect of the test inoculation and was, therefore, highly selec- 
tive.  From the biological viewpoint, it is questionable whether results with 
such selected animals are completely reliable.  Bearing this in mind, we have 
chosen to present for main consideration only those tests on vaccines in which 
mortalities from other causes have been not greater than 5  per  cent of the 
original population. 
Results of Tests on Vaccinated Dogs 
The first experiment was planned to determine whether a calculated amount 
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dogs  and, at the same time, whether  the immunity obtained would compare 
favorably with that achieved by commercial canine vaccines. 
Experiment 1, Test 10, October 16, 1939.--A  1 per cent mouse brain irradiated vac- 
cine was prepared as described above.  Prior to irradiation the i per cent vaccine titred 
330,000 mouse doses per cc.  8 days later, ten dogs, groups B and D, were each given 
40 cc. of this vaccine in a single dose intraperitoneaUy and 5 dogs, group E, were each 
given 10 cc.  An additional five dogs, group F, were each given a single 5 cc. dose of 
a  commercial  33  per  cent chloroformized canine vaccine subcutaneously, and still 
TABLE II 
Immunizing Effects of Antirabies  Vaccines on Beagle Dogs 
Experiment 1, Test 10 
Treatment of dogs 
A. No vaccine 
B. Vaccine: irradiated, 40 cc., intraperitoneally 
C.  No vaccine 
D. Vaccine: irradiated, 40 cc., intraperitoneally 
E.  Vaccine: irradiated, 10 cc., intraperitoneally 
F.  Vaccine: chloroform, 5 cc., subcutaneously 
G. Vaccine: phenol, 5 cc., subcutaneously 
H. No vaccine 
Dilution 
of test 
virus 
:4OO 
at 
:4,0O0 
:40,00 
Fate of dogs inoculated into 
the neck muscles  (right and left) 
with 0.25 co. of dog passage 
virus No. 15811 
No•  Day of death  dead/ 
following  Dead  No.  in 
inoculation  iectofl 
per 
cent 
13,20,S  2/3  66 
S,S,S,S  0/4  0 
15,16,18,30,S  4/5  80 
53,S,S,S,S  1/5  20 
S,S,S,S,S  0/5  0 
15,19,S,S,S  2/5  40 
14,16,17,43,S  4/5  80 
12,39,S,S  2/4  50 
S =  animal remained well following injection.  Survivors discarded after 70 days. 
another five dogs, group G, a single 5 cc. dose of a commercial phenolized canine vac- 
cine subcutaneously.  Twelve remaining dogs were set aside as  controls.  3  weeks 
later, all save one dog in group B, which died of distemper, were ready for the test in- 
oculation of virulent virus.  A strain of dog passage virus, No. 15811, which had been 
employed in previous tests (2), was prepared as described above and given into the 
neck muscles of the dogs in the following manner•  Group B, plus a group of three 
controls (group A), received an injection of 0.25 cc. of a  1:400 dilution into the neck 
muscles of each side; groups D, E, F, and  G, plus five controls (group C), the same 
inoculation of  a  1: 4,000  dilution, and four controls (group H), a  1:40,000 dilution. 
Animals were observed 70 days. 
The results of this test are shown in Table II.  Of greatest interest are the 
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been shown to produce rabies in 50 per cent and less than 100 per cent of con- 
trols and to contain roughly about ten lethal doses for dogs (3).  In the present 
test, this amount of virus was fatal to four of five unvaccinated  dogs (80 per 
cent), (group C), and one-tenth of this amount was fatal to two of four unvac- 
cinated dogs (group H).  The 1:4,000  dilution of virus was likewise fatal to 
four of five dogs receiving phenolized vaccine (80 per cent),  (group G), to two 
of five receiving chloroformized vaccine (40 per cent),  (group F), but to only 
one of five receiving 40 cc. of irradiated vaccine (20 per cent), (group D), and 
to none of five receiving 10 cc. of the irradiated vaccine (group E).  Finally, 
ten times this dose of test virus was fatal to two of three controls (66 per cent), 
(group A), but to none of four dogs receiving 40 cc. of irradiated vaccine (group 
B).  Clearly the irradiated vaccine in 40 or 10 cc. amounts conferred a strong 
TABLE  III 
Immunizing Effects of an Irradiated Antirabies Vaccine on Beagle Dogs 
Experiment 2, Test 13 
Treatment of dogs 
A.  No vaccine 
B.  Vaccine:  irradiated,  10  cc.,  in- 
traperitoneally 
C.  Vaccine:  irradiated,  2  doses,  10 
cc. each, intraperitoneally 
Dilution 
of test 
virus 
1:400 
Fate of dogs inoculated into the neck muscles (right and 
left) with 0.25 cc. of dog passage virus No. 15811 
No. dead/  Day of death following inoculation  No. injected 
15,17,18,18,20,28,34,S,S  7/9 
17,19,24,29,31,38,S,S,S,S  6/10 
17,17,S,S,S,S,S,S 
Dead 
per  cenl 
77.7 
60.0 
2/8  25.0 
immunity to thirteen of fourteen dogs, whereas phenolized vaccine failed and 
chloroformized vaccine succeeded only partially in immunizing the animals. 
Inasmuch as 10 cc. or more of irradiated vaccine immunized dogs successfully 
in Experiment 1, the test was repeated using 10 cc. or 20 cc. of vaccine per dog. 
Experiment 2, Test 13, April 8, 1940.--A 1 per cent dog brain irradiated vaccine was 
prepared in the manner described above.  Prior to irradiation,  1  per  cent  vaccine 
titred 3,300,000 mouse doses per cc.  15 days later, ten dogs, group B, were given a 
single  dose of 10 cc. of the vaccine intraperitoneally, and eight dogs, group C, two 
doses  of  10  cc.  1 week apart.  Ten dogs, group A, were set aside as controls.  3 
weeks later, all dogs were given the stated inoculation of virulent dog passage virus, 
strain 15811, diluted 1:400, and observed for 70 days. 
The results  of this test are shown in Table III.  One  of the  control dogs 
(group A) died of distemper on the 22nd day.  Of the remaining nine, seven 
died  of rabies  (77.7  per  cent).  Six  of ten  dogs  receiving  10  cc.  of vaccine 
(group B) also died of rabies (60 per cent), whereas only two of eight receiving 190  NON-VIRULENT, SINGLE-DOSE RABIES VACCINE 
two 10 cc. doses of vaccine (group C) succumbed (25 per cent).  Evidently in 
this test 10 cc. of vaccine produced little immunity and 20 cc. a good immunity. 
In the following experiment a  larger amount of irradiated vaccine was em- 
ployed-30  cc. in a  single dose and in three doses of 10 cc. each. 
Experiment 3, Test 16, October 10, 1940.--A  1 per cent dog brain virus was prepared 
and tested as in the previous experiment.  Its titre prior to irradiation was 3,300,000 
mouse doses per cc.  9 days later eight dogs were given a single injection of 30 cc. of 
vaccine intraperitoneally (group B), and eight dogs three injections of 10  cc.  each 
(group C).  Eight dogs (group A) were reserved as controls.  3 weeks later, all but 
one dog in group B and one in C, which died of distemper, were inoculated into the 
TABLE IV 
Immunizing Effects of Irradiated Antirabies  Vaccine on Beagle Dogs 
Experiment 3, Test 16 
Treatment of dogs 
A. No vaccine 
B.  Vaccine: irradiated, 30 cc., intraperi- 
toneally 
C.  Vaccine:  irradiated,  3  doses,  10  cc. 
each, intraperitoneally 
Dilutio: 
of test 
virus 
1:20 
~¢ 
Fate of dogs inoculated into the neck muscles 
(right and left) 
with 0.23 ce. of one-passage virus No. 17456 
Day of death following 
inoculation 
17,20,25,27,30,30,37,41 
S,S,S,S,S,S,S 
S,S,S,S,S,S,S 
N° Ni.ead/ 
injected  Dead 
per cent 
8/8  100 
0/7  0 
0/7 
neck muscles with one-passage street virus, No.  17456,  diluted 1: 20.  The animals 
were observed for rabies for 70 days. 
The results of this test, shown in Table IV, were clear-cut.  All of the con- 
trols died of rabies but none of the fourteen vaccinated dogs.  A  total of 30 cc. 
of  irradiated  vaccine  either  in  single  or  multiple  doses  conferred  a  strong 
immunity, as already indicated in Experiment 1. 
It was apparent from these tests that  25  to 30 cc.  of 1 per cent irradiated 
vaccine would immunize young beagle dogs against an inoculation of fixed or 
street  virus  fatal to  nearly all  unvaccinated  dogs.  It remained  to  discover 
whether the same amount of vaccine concentrated to a  smaller volume would 
be equally effective as an immunizing agent. 
Experiment 4, Test lg, May 27, 1941.--A 5 per cent rather than a  1 per cent super- 
natant dog brain virus was prepared as a vaccine, thus effecting at once a 5 times con- 
centration of virus per cubic centimeter.  This material titred 33,000,000 mouse doses 
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the 5 per cent vaccine was concentrated 6 times at low temperature in vacuo.  27 days 
later eight dogs (group B) were given a single dose of 5 cc. intraperitoneally, eight dogs 
(group C) 5 cc. subcutaneously, eight dogs (group D) two injections of 5 cc. each intra- 
peritoneally, and eight dogs (group E) 5 cc. of a commercial chloroformized vaccine 
subcutaneously.  Eight dogs were reserved as controls.  3 weeks later, all received 
the standard inoculation into the neck muscles of one-passage street virus, No. 17825, 
diluted 1:20.  The animals were observed 70 days for signs of rabies. 
The results of this test were again striking  (Table V).  Seven of the eight 
control dogs (group A) died of rabies in 12 to 19 days (87.5 per cent), indicating 
an  unusually  virulent  street  virus.  Three  of  the  eight  dogs  given  chloro- 
TABLE  V 
Immunizing Effects of Irradiated Antirabies  Vaccine on Beagle Dogs 
Experiment 4  Test 18 
Treatment of dogs 
A.  No vaccine 
B.  Vaccine:  irradiated,  concentrated,  5 
cc., intraperitoneally 
C.  Vaccine:  irradiated,  concentrated,  5 
cc., subcutaneously 
D. Vaccine:  irradiated,  concentrated,  2 
doses, 5 cc. each intraperitoneally 
E.  Vaccine:  chloroform,  5  cc.  sub- 
cutaneously 
Fate of dogs inoculated into the neck muscles 
(right and left) 
with 0.25 cc. of one-passage street virus 
Day of death following 
inoculation 
12,13,13,13,13,19,19,S 
S,S,S,S,S,S,S,S 
S,S,S,S,S,S,S,S 
S,S,S,S,S,S,S,S 
12,13,19,S,S,S,S,S 
No. dead/ 
No.  Dead 
injected 
per cent 
7/8  87.5 
0/8  0.0 
0/'8  0.0 
O/8  0.0 
3/8  37.5 
formized vaccine (37.5 per cent) likewise died of rabies (group E), whereas all of 
the  twenty-four dogs  given  irradiated  vaccine  remained  well.  It appears, 
therefore, that  5  cc.  or  more  of  this  concentrated  vaccine  protects  highly 
susceptible dogs against  rabies. 
Having demonstrated that a single 5 cc. dose of our non-virulent rabies vac- 
cine immunized dogs effectively, we sought information from all of our tests as 
to  (1)  the  comparative  effectiveness in  dogs  of irradiated,  phenolized,  and 
chloroformized vaccines, and (2) the comparative effectiveness of the intraperi- 
toneal as opposed to the subcutaneous route of injecting the vaccine. 
With respect to the relative immunizing potencies of irradiated as compared 
to phenolized or chloroformized vaccines, the following information is at hand. 
Summarizing all data in nineteen dog tests (Table VI), we noted that the mor- 
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to vaccinated animals was 92.2 per cent.  Similarly, the mortality of fifty-three 
dogs given commercial phenolized vaccine according to directions was 77.3 per 
cent and that of fifty dogs  given commercial chloroformized vaccine, 46.0 per 
cent.  In contrast, of thirty-eight dogs given 20 to 40 cc. of irradiated vaccine 
intraperitoneally,  13.1 per cent succumbed, and of thirty-one given 5 to 10 cc. 
of irradiated vaccine, concentrated, only one succumbed to the test inoculation 
of virulent virus.  Clearly the  course of vaccination with  irradiated  vaccine 
appears far superior to that of vaccination with commercial vaccines. 
From the figures of Table VI alone,  however,  one would  rightly question 
whether the superior results with irradiated vaccine were due only to the quality 
of the material, or to the greater amounts employed and to the routes of inocu- 
lation.  It is our belief that all three factors contribute to the potency of the 
TABLE VI 
Comparison of Commercial (Phenolized, Chloroformlzed) and  Irradiated Canine Antirabies 
Vaccines 
Total dead/  Dead 
Groups  Total tested 
A.  Controls.  Fixed virus, dilution 1:50 to  1:10,000; street virus 
dilution 1 : 20 
B. Vaccinated.  Phenolized vaccine, 5 cc., subcutaneously 
C. Vaccinated.  Chloroformized  vaccine, 5 cc., subcutaneously 
D. Vaccinated.  Irradiated brain tissue supernatant: 
1.  20-40 cc., intraperitoneally 
2.  5-10 cc. concentrated, intraperitoneally 
130/141 
41/53 
23/50 
S/3S 
1/31 
l~er c~J 
92.2 
77.3 
46.0 
13.1 
3.2 
irradiated vaccine and the following reasons are emphasized.  That irradiated 
vaccine given intraperitoneally is superior to equal quantities of chloroformized 
vaccine given by the same route is indicated by the quantitative results of three 
experiments (1) in which one part of a single pool of virus material was inacti- 
vated by chloroform and another part by irradiation.  Each inactivated prepa- 
ration was then given to mice as vaccine and in each instance  the irradiated 
sample proved equal  in  immunizing potency or  superior  to  the  chloroform- 
treated sample.  In further tests,  the irradiated  vaccine was compared with 
commercial canine vaccines for ability to immunize dogs.  The results shown 
in Table VII, though not critical, confirm the findings in mice.  The vaccines 
contained widely different amounts of brain-virus--33 per cent to i  per cent-- 
and were inoculated into dogs in different amounts.  Hence, for purposes of 
comparison, it seemed best to reduce the dose of each vaccine to an equivalent 
amount of 1 per cent emulsion.  Thus, dogs of group A, given 5 cc. of 20 per 
cent vaccine, are said to have received 100 cc. of 1 per cent vaccine.  On this 
basis,  among dogs of groups A,  B,  and  C  receiving vaccine subcutaneously, L.  T.  WEBSTER AND ~'.  CASALS  193 
group C, given irradiated vaccine in a dose equivalent to 150 cc., suffered only 
9.1  per cent mortality, in contrast to 46 per cent by group B, given a  similar 
equivalent dose of chloroformized vaccine, and 77.3 per cent by group A, given 
phenolized vaccine.  Again, among groups vaccinated intraperitoneally, group 
]3, given phenolized vaccine in a dose equivalent to 500 cc., suffered a mortality 
of 22.2 per cent and group E, with a  similar dose of chloroformized vaccine, 
18.5 per cent, as contrasted with 10 per cent by group F, given only 30 to 40 cc. 
of 1 per cent irradiated vaccine, or less than one-tenth of that given to groups 
D  and  E,  and  3.2  per cent  by group  G,  given  150  to  300  cc.  of irradiated 
vaccine. 
TABLE VII 
Relative Amounts  of Irradiated, Phenolized, and Chloroformized Vaccines Reguired to 
Immunize Dogs 
Group 
A. Vaccinated subcutaneously--phenolized 20 per cent, 5 cc. 
B.  Vaccinated subcutaneously--chloroformized 33 per cent, 
5  CC. 
C. Vaccinated subcutaneously--irradiated  5 per cent, concen- 
trated 6 times, 5 cc. 
D. Vaccinated  intraperitoneally--phenolized  20  per  cent, 
25 cc. 
E.  Vaccinated intraperitoneally--chloroformized 33 per cent, 
10-25 cc. 
F.  Vaccinated  intraperitoneally--irradiated  1  per  cent, 
30-40 cc. 
G. Vaccinated intraperitoneally--irradiated  5 per cent, con- 
centrated 6 times, 5-10 cc. 
Equivalent 
~mount of 
1 per .cent 
vaccine 
CO. 
100 
150 
150 
500 
330-825 
30-40 
150-300 
41/53 
23/50 
1/11 
2/9 
5/27 
3/30 
1/31 
Total 
dead/Total  Dead 
for test 
per cent 
77.3 
46.0 
9.1 
22.2 
18.5 
10.0 
3.2 
Actually these comparisons shou]d be made not in terms of equivalent dose 
of 1 per cent vaccine but number of mouse lethal doses contained in the original 
vaccine material (1).  This information is not obtainable for the commercial 
canine vaccines but for the irradiated preparations we find from the present 
tests that 10 cc. of the 1 per cent vaccine contains about 3  X  l0 T mouse doses 
and that this does not give the best immunity according to our rigid test; 5 X 
l0 T or 108 doses, however, immunize dogs well. 
The question of whether vaccine is more effective if given intraperitoneaUy 
rather than subcutaneously has not yet been definitely answered.  Certainly 
in mice, the intraperitoneal is the route of choice (1).  In dogs, however, the 
evidence is less  convincing.  Johnson  and Leach  (6)  interpret  their  tests as 
showing the subcutaneous route to be more effective than the intraperitoneal, 194  NON-VIRULENT, SINGLE-DOSE RABIES VACCINE 
whereas our data, though not based on tests especially planned to decide this 
question, suggest that there is little difference between the two routes but that 
the intraperitoneal is slightly preferable. 
COUNT  AND  SIYMIM.ARY 
Our studies on rabies vaccines thus far have led us to the view that in order 
to develop and test vaccines, quantitative methods are necessary, and that such 
quantitative methods may be exploited to greatest advantage by using mice, 
preferably W-Swiss, as the test animal.  Dogs, due to their variability and sus- 
ceptibility to intercurrent infections when kept under experimental conditions, 
are useful chiefly to check whether or not a vaccine produces a high grade of 
immunity; they remain of limited value in testing the comparative potencies of 
weak vaccines.  A second point is that the Pasteur strain of virus has proved 
as potent as any tested for the preparation of vaccines.  1  Another point is that 
virus material for preparing vaccines must  titre at ]east 330,000 mouse doses 
per  cc.  to  be  effective.  This  requirement  has  eliminated  all  culture  vac- 
cines thus far reported, with the possible exception of Plotz's (7) and leaves 
virus-containing brain tissue as the sole potent source of vaccine. 
In summary, we believe that  a  sing]e  injection of non-viru]ent irradiated 
vaccine, prepared as  herein described,  immunizes mice  and  dogs  effectively 
against a subsequent test inoculation of virulent rabies virus and does so to a 
greater degree than do other vaccines now obtainable.  It is easily and quickly 
prepared, keeps well, and has a low nitrogen content. 
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